# AMVUTTRA

NDC: 71336-1003
Generic name: VUTRISIRAN
Labeler / Manufacturer: Alnylam Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20220613

FDA application: NDA215515

## Active ingredients

- VUTRISIRAN SODIUM: 25 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71336-1003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71336-1003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8db0facb-81b6-4006-9239-27dc6409c5d3